Connect with us

Business

Marimed Inc (OTCMKTS:MRMD) Introduces Award-Winning And Proprietary National Cannabis Brand – Betty’s Eddies In Massachusetts

Published

on

Marimed Inc (OTCMKTS:MRMD) has introduced its award-winning and proprietary national cannabis brand – Betty’s Eddies in Massachusetts. The Betty’s Eddies fruit chews are available in adult cannabis and medical cannabis programs in Massachusetts in multi-flavor packs such as Seasonal Apple Pie, Betty’s Bedtime, and individual flavor packs. They are vegan and gluten-free and manufactured using organically grown vegetables and fruits.

Betty’s Eddies feature full-spectrum cannabis oil

Betty’s Eddies fruit chews feature full-spectrum cannabis oil. The patients and consumers can choose these fruit chews in both increased and lower dosages that comply with the adult-use and medical use regulations. Marimed produces Betty’s Eddies at its New Bedford based manufacturing facility.

Available at all the dispensaries in MA

After introducing at the medical cannabis program in Middleborough last week, Marimed offers these products at all the licensed adult-use and medical dispensaries in the state. It also offers Betty’s Eddies and other cannabis brands in medical programs in Illinois, Rhode Island, Maryland, and Delaware. Marimed will soon expand these products to adult-use programs in Illinois, and Nevada, and the medical program in Puerto Rico.

Senior Vice President (sales) and Chief Product Officer of Marimed, Ryan Crandall, said the company achieved significant growth in the sale of Betty’s Eddies last year. The company now focuses on expanding these successful products to both the new and existing markets in 2020.

According to recent studies, cannabis-infused products will garner a significant share in the US cannabis market. The sales of cannabis-infused products would reach $12 billion (up 35%) in 2020. Chief Executive Officer of Marimed, Bob Fireman, said the company achieved a significant milestone by expanding Betty’s Eddies to Massachusetts. The company expects to generate significant revenues going forward as it expands these products to several regions this year.

Marimed owns thirteen cannabis licenses in six states in the US. It operates more than 300,000 Sq. Ft. facilities across the US and plans for expansion across the world. The company’s MariMed Hemp division is engaged in the development of hemp-derived CBD products. Marimed also holds a stake of 33.5% in GenCanna Global, which is engaged in the manufacture of CBD isolates and oil.

*Past performance is not a predictor of future results. All investing involves risk of loss and individual investments may vary. The examples provided may not be representative of typical results. Your capital is at risk when you invest – you can lose some or all of your money. Never risk more than you can afford to lose.By submitting your information you agree to the terms of our Privacy Policy • Cancel Newsletter Any Time.This is a FREE service from Finacials Trend. Signing up for our FREE daily e-letter also entitles you to receive this report. We will NOT share your email address with anyone.

FEATURED STORIES

Business23 hours ago

Planet 13 Holdings Inc. (OTCMKTS:PLNHF) Signs Purchase Agreement To Acquire 45,000 Sq. ft. Facility In Nevada

Post Views: 119 Planet 13 Holdings Inc. (OTCMKTS:PLNHF) announced the signing of an asset purchase agreement subject to which it...

Business2 days ago

Indus Holdings Inc. (OTCMKTS:INDXF) Terminates Its Pending $20 million Acquisition Agreement Of W Vapes Assets

Post Views: 149 Indus Holdings Inc. (OTCMKTS:INDXF) announced termination of its impending acquisition of W Vapes assets that was announced...

Business2 days ago

1933 Industries Inc. (OTCMKTS:TGIFF) Introduces Pre-roll Joints And Smokable Cannabis Flower In Nevada

Post Views: 137 1933 Industries Inc. (OTCMKTS:TGIFF) announced addition of pre-joint rolls and high-quality smokable flowers to its growing consumer...

Business3 days ago

Cannabis Pharmaceuticals Inc. (OTCMKTS:CNBX) Initiates Expansion Of Its Cannabinoid Diagnostic Platform Tests In Europe

Post Views: 66 Cannabis Pharmaceuticals Inc. (OTCMKTS:CNBX) commenced expansion in the European markets to offer cancer patients tailored cannabinoid treatment...

INDUSTRIAL HEMP3 days ago

Generex Biotechnology Corporation (OTCMKTS:GNBT) Submits Pre-IND For Ii-Key-SARS-CoV-2 Vaccine To The FDA

Post Views: 201 Generex Biotechnology Corporation (OTCMKTS:GNBT) submitted a Pre-IND update to the FDA outlining its proposed Phase I/II clinical...

Business6 days ago

cbdMD Inc. (NYSEAMERICAN:YCBD) Protecting Its CBD Technologies Through Patents and expands Partnership With Bellator MMA

Post Views: 310 cbdMD Inc. (NYSEAMERICAN:YCBD) announced an extension of the exclusive Official CBD marketing partnership with ViacomCBS’s wholly-owned subsidiary...